Crypto for Advisors: The blockchain built to run financial markets

Crypto for Advisors: The blockchain built to run financial markets

**Happy Thursday, advisors!**

Then, in “Ask an Expert,” Kieran Mitha explains why advisors should watch the infrastructure taking shape, whatever they think of the token.

**Injective builds financial markets into its blockchain**

Most layer-1 blockchains are neutral platforms that leave developers to build market infrastructure themselves. Injective takes the opposite approach, building core financial plumbing directly into the base layer. As traditional assets move onchain, that choice makes it a useful case study in whether specialized infrastructure can compete with general-purpose networks.

Founded in 2018 by Eric Chen and Albert Chon, Injective began as a decentralized derivatives venue and has grown into a financial layer-1 supporting spot and derivatives markets, lending, stablecoins and tokenized real-world assets.

A blockchain built around markets

Grayscale opens in-kind crypto ETF investing to more investors

0 seconds of 11 minutes, 12 seconds Volume 0%

Press shift question mark to access a list of keyboard shortcuts

Keyboard Shortcuts Enabled Disabled

Shortcuts Open/Close/ or ?

Fullscreen/Exit Fullscreen f

Decrease Caption Size-

Increase Caption Size+ or =

CZ on Binance's $6.3B hack

0.5x 1x 1.25x 1.5x 2x

Auto 1080p 720p 406p 270p 180p

Its Multi-Virtual-Machine (MultiVM) architecture lets native modules, WebAssembly contracts and, since November 2025, a native Ethereum Virtual Machine run over shared state, so Ethereum developers can bring existing code without rebuilding. Connections to Cosmos chains via Inter-Blockchain Communication (IBC), to Ethereum and to Solana aim to make Injective connective tissue for liquidity scattered across networks.

Real-world assets and institutional adoption

Tokenization is where that infrastructure meets a larger market. In August 2026, Injective Institutional Services became an SEC-registered transfer agent, giving it a recognized role in maintaining official securities ownership records. Injective Mint, launched in July 2026, lets issuers enforce holder restrictions, jurisdictional controls and redemption permissions.

Early use cases span several corners of finance. Pineapple Financial has moved more than $1 billion in mortgage records onchain; POSCO International and LG CNS are piloting tokenized trade receivables; and through Libre, Injective offers access to tokenized funds associated with BlackRock, Hamilton Lane and Nomura’s Laser Digital, including private credit. Tokenized assets that trade and settle on Injective generate fees, linking this activity to INJ.

INJ and the buyback-and-burn

INJ pays fees, secures the network through staking and carries governance votes. Like most proof-of-stake tokens, new INJ is issued as staking rewards; Injective offsets this by burning tokens funded by ecosystem revenue. Under the Community BuyBack introduced in 2025, participants commit INJ each month in exchange for a pro-rata share of the revenue pool, and the committed INJ is permanently burned. A 2026 upgrade narrowed annual issuance to between 2.20% and 4.40%.

Risks and investment thesis

Adoption remains early. Decentralized finance (DeFi) total value locked was about $18 million in October 2026, according to DefiLlama, though order-book markets rely less on deposited capital. Larger networks are pursuing the same tokenization opportunity, many institutional initiatives are still pilots, regulation could add compliance burdens, and INJ remains volatile.

Injective offers a differentiated approach to blockchain-based finance, combining purpose-built infrastructure, growing institutional interest in tokenization and a buyback-and-burn mechanism designed to connect ecosystem activity with token supply. As institutional pilots mature and onchain financial activity expands, Injective has an opportunity to translate adoption into sustained protocol revenue and stronger token economics.

—Josh Olszewicz, market analyst, Canary Capital

**Ask an Expert**

Q: What exactly is Injective, and how is it different from other blockchains?

Injective is a layer-1 blockchain built with financial applications in mind. Unlike Ethereum or Solana, which support everything from gaming to digital collectibles, Injective has focused much of its development on trading, lending and other financial services. Rather than trying to accommodate every possible use case, it’s designed to give developers the tools they need to build financial products.

Think of it as infrastructure built specifically for financial markets. The idea is to make it easier for developers to create applications without having to build every component from scratch. For advisors, the interesting part isn’t necessarily the technology itself but what it could eventually mean for how financial products are created, traded and managed.

Q: Why should financial advisors care about a blockchain like Injective?

Most advisors probably aren’t going to recommend Injective to their clients tomorrow, and that’s not really the point. What’s worth paying attention to is the type of financial infrastructure being developed. Traditional markets rely on exchanges, clearinghouses, custodians and other intermediaries to keep things running. Blockchains like Injective are experimenting with ways to handle some of these functions through a shared network.

Think about tokenization, for example. We’re already seeing financial institutions explore how bonds, investment funds and other assets can be issued and managed on blockchain networks. For clients, this could eventually mean access to new types of investment products or improvements in how existing ones are managed and settled. That doesn’t mean traditional financial systems are going away, but it does suggest that some of the technology behind them could change.

For advisors, it’s less about learning the technical details of every new blockchain and more about recognizing where the financial industry might be heading.

Q: What are the risks, and what should advisors keep in mind?

There’s still a big difference between building interesting technology and getting people to actually use it. Injective is competing with much larger blockchain ecosystems, including Ethereum and Solana, both of which have established developer communities and financial applications. Whether Injective can attract enough users, developers and liquidity over the long term remains an open question.

Injective is a useful example of how blockchain technology is becoming more specialized, particularly around financial services. Advisors don’t need to become experts in every network, but understanding what these projects are trying to solve is a good starting point for more informed conversations with clients.

—Kieran Mitha, marketing coordinator

**Keep Reading**

The New York Stock Exchange announces it will use the Avalanche blockchain network exclusively to settle tokenized stocks on its upcoming 24/7 trading platform, targeting a fourth quarter launch pending regulatory approval.

Goldman Sachs, Citi among banks said to commit $270 million tostablecoin venture.

Looking for more? Receive the latest crypto news from coindesk.com and market updates from coindesk.com/institutions.

1. 1DTCC adds Solana to Wall Street tokenization plans, targeting 2027 rollout15 minutes ago

2. 2Jupiter adds Anchorage-backed USDGO to its $1 billion Solana lending platform1 hour ago

3. 3The next Congress will write rules for AI and emerging tech. They should use the stuff first.1 hour ago

4. 4Nvidia CEO Huang quits company he co-founded, led for 3 decades. Shares slump2 hours ago

5. 5Bitcoin weakness erases September's bullish signal3 hours ago

6. 6UK bank Griffin raises $20 million to expand into stablecoin payments3 hours ago

8. 8Bitcoin dips with Nvidia as ETF outflows reach day five4 hours ago

9. 9Polymarket trims workforce under investor pressure as Kalshi surges ahead5 hours ago

10. 10Nomura weighs Laser Digital sale as European losses hit four straight quarters5 hours ago

Diversified RWA stablecoins sustain 5-7% yield from real credit as crypto funding compresses to ~4%. GENIUS pushes yield off-chain; TAM grows to $4B in 3 years.

Commissioned byRealFi

Diversified RWA stablecoins sustain 5-7% yield from real credit as crypto funding compresses to ~4%. GENIUS pushes yield off-chain; TAM grows to $4B in 3 years.

Diversified RWA stablecoins sustain 5-7% yield from real credit as crypto funding compresses to ~4%. GENIUS pushes yield off-chain; TAM grows to $4B in 3 years.